Trial Outcomes & Findings for What is the Efficiency When Comparing Active Sentry at Low IOP vs Ozil at High IOP? (NCT NCT05868772)
NCT ID: NCT05868772
Last Updated: 2025-04-17
Results Overview
Recruitment status
COMPLETED
Target enrollment
36 participants
Primary outcome timeframe
Day of surgery (Day 0)
Results posted on
2025-04-17
Participant Flow
Unit of analysis: eyes
Participant milestones
| Measure |
Overall (All Participants)
Contralateral eye study, flow includes all participants.
One eye was randomly assigned to either the Active Sentry or Ozil group and the other eye was assigned to the opposite group.
|
|---|---|
|
Overall Study
STARTED
|
36 72
|
|
Overall Study
Active Sentry
|
36 36
|
|
Overall Study
Ozil
|
36 36
|
|
Overall Study
COMPLETED
|
36 72
|
|
Overall Study
NOT COMPLETED
|
0 0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Overall (All Participants)
n=36 Participants
Contralateral eye study, flow includes all participants
|
|---|---|
|
Age, Continuous
|
71.3 years
STANDARD_DEVIATION 6.7 • n=36 Participants
|
|
Sex: Female, Male
Female
|
19 Participants
n=36 Participants
|
|
Sex: Female, Male
Male
|
17 Participants
n=36 Participants
|
PRIMARY outcome
Timeframe: Day of surgery (Day 0)Outcome measures
| Measure |
Active Sentry Handpiece
n=36 eyes
At low IOP settings
Active Sentry Handpiece: With low IOP settings
|
Ozil Handpiece
n=36 eyes
At high IOP settings
Ozil Handpiece: With high IOP settings.
|
|---|---|---|
|
Total Aspiration Time
|
90.1 seconds
Standard Deviation 16.4
|
85.1 seconds
Standard Deviation 17.0
|
SECONDARY outcome
Timeframe: Day of surgery (Day 0)Outcome measures
| Measure |
Active Sentry Handpiece
n=36 eyes
At low IOP settings
Active Sentry Handpiece: With low IOP settings
|
Ozil Handpiece
n=36 eyes
At high IOP settings
Ozil Handpiece: With high IOP settings.
|
|---|---|---|
|
Total Fluid Volume
|
32.8 mL
Standard Deviation 4.6
|
33.8 mL
Standard Deviation 6.0
|
SECONDARY outcome
Timeframe: Day of surgery (Day 0)Outcome measures
| Measure |
Active Sentry Handpiece
n=36 eyes
At low IOP settings
Active Sentry Handpiece: With low IOP settings
|
Ozil Handpiece
n=36 eyes
At high IOP settings
Ozil Handpiece: With high IOP settings.
|
|---|---|---|
|
Total Phaco Time
|
29.5 seconds
Standard Deviation 7.3
|
31.0 seconds
Standard Deviation 7.4
|
SECONDARY outcome
Timeframe: 1 week postoperativeOutcome measures
| Measure |
Active Sentry Handpiece
n=36 eyes
At low IOP settings
Active Sentry Handpiece: With low IOP settings
|
Ozil Handpiece
n=36 eyes
At high IOP settings
Ozil Handpiece: With high IOP settings.
|
|---|---|---|
|
Central Corneal Thickness
|
554.9 um
Standard Deviation 27.6
|
555.5 um
Standard Deviation 28.8
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Day of surgery (Day 0)CDE is the amount of ultrasound energy used to remove a cataractous lens. CDE is the power and time of torsional and longitudinal ultrasound delivery modes. It is not expressed in standard units, but is generally unitless. CDE is calculated by the Centurion® Vision System automatically. A lower value is indicative of lower energy used in the eye.
Outcome measures
| Measure |
Active Sentry Handpiece
n=36 eyes
At low IOP settings
Active Sentry Handpiece: With low IOP settings
|
Ozil Handpiece
n=36 eyes
At high IOP settings
Ozil Handpiece: With high IOP settings.
|
|---|---|---|
|
Cumulative Dissipated Energy (CDE)
|
5.0 unitless
Standard Deviation 1.9
|
5.2 unitless
Standard Deviation 1.7
|
Adverse Events
Active Sentry Handpiece
Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths
Ozil Handpiece
Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Active Sentry Handpiece
n=36 participants at risk
With low IOP settings
|
Ozil Handpiece
n=36 participants at risk
With high IOP settings
|
|---|---|---|
|
Eye disorders
corneal edema
|
0.00%
0/36 • 1 week
|
2.8%
1/36 • 1 week
|
|
Eye disorders
iritis
|
0.00%
0/36 • 1 week
|
2.8%
1/36 • 1 week
|
|
Eye disorders
Elevated IOP
|
2.8%
1/36 • 1 week
|
2.8%
1/36 • 1 week
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place